| Old Articles: <Older 1221-1230 Newer> |
 |
The Motley Fool June 2, 2004 Tom Taulli |
ViroLogic's Very Logical Deal ViroLogic has proven its abilities in HIV and AIDS. The next step is the cancer market.  |
The Motley Fool June 2, 2004 Brian Gorman |
New Injection for Genzyme A partnership with Medtronic bolsters Genzyme's myoblast cell therapy program.  |
IndustryWeek June 1, 2004 Tonya Vinas |
Amgen's Land Of Discovery Biotechnology behemoth Amgen Inc., based in Thousand Oaks, Calif., further capitalized on its acquisition of Immunex Corp. with the opening of a $625 million research and development campus in Seattle in February.  |
Fast Company June 2004 Bill Breen |
The Thrill of Defeat Want to know how to motivate people to take on tough odds? Ask the folks in Pfizer's labs, where managing failure is a fine art and superhuman persistence an everyday habit.  |
The Motley Fool June 1, 2004 Jeff Hwang |
Expanding Boston Scientific The medical device maker takes advantage of Taxus sales to expand.  |
Managed Care May 2004 Frank Diamond |
Care Coordination Strikes Right Chord Care coordination -- which, for the purposes of this article, means optimal management of people with multiple chronic diseases to improve outcomes and cut costs -- just suddenly seems a lot more doable. The thing that may make care coordination work this time, is technology.  |
Managed Care May 2004 Thomas G. Dolan |
Pharmacist Care An Idea Whose Time Is Still Coming For more than a decade, it has seemed this idea would catch fire. But many insurers are still looking for evidence that it can reduce overall costs.  |
Managed Care May 2004 Dodick & Lipsy |
Advances in Migraine Management: Implications for Managed Care Organizations In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm.  |
Managed Care May 2004 |
Biologics Among Fastest Growers Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs.  |
Managed Care May 2004 John Carroll |
Bush vs. Kerry: Upcoming Election Offers Real Debate on Health Care Despite the focus on the international situation, Americans are still keenly interested in just how they'll get the medical care they need.  |
| <Older 1221-1230 Newer> Return to current articles. |